Logo image of CSSE

CHICKEN SOUP FOR THE SOUL EN (CSSE) Stock Fundamental Analysis

NASDAQ:CSSE - Nasdaq - US16842Q1004 - Common Stock - Currency: USD

0.1055  -0.01 (-10.21%)

After market: 0.054 -0.05 (-48.82%)

Fundamental Rating

2

CSSE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 72 industry peers in the Entertainment industry. Both the profitability and financial health of CSSE have multiple concerns. CSSE has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CSSE has reported negative net income.
In the past year CSSE has reported a negative cash flow from operations.
In the past 5 years CSSE always reported negative net income.
CSSE had a negative operating cash flow in each of the past 5 years.
CSSE Yearly Net Income VS EBIT VS OCF VS FCFCSSE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200M -400M -600M

1.2 Ratios

With a Return On Assets value of -152.35%, CSSE is not doing good in the industry: 92.11% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -152.35%
ROE N/A
ROIC N/A
ROA(3y)-62.52%
ROA(5y)-47.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CSSE Yearly ROA, ROE, ROICCSSE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CSSE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CSSE Yearly Profit, Operating, Gross MarginsCSSE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 200 -200

More info and screens

0

2. Health

2.1 Basic Checks

CSSE does not have a ROIC to compare to the WACC, probably because it is not profitable.
CSSE has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CSSE has more shares outstanding
CSSE has a worse debt/assets ratio than last year.
CSSE Yearly Shares OutstandingCSSE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
CSSE Yearly Total Debt VS Total AssetsCSSE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of -4.31, we must say that CSSE is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -4.31, CSSE is doing worse than 81.58% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -4.31
ROIC/WACCN/A
WACC1.09%
CSSE Yearly LT Debt VS Equity VS FCFCSSE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M -400M

2.3 Liquidity

A Current Ratio of 0.53 indicates that CSSE may have some problems paying its short term obligations.
The Current ratio of CSSE (0.53) is worse than 75.00% of its industry peers.
CSSE has a Quick Ratio of 0.53. This is a bad value and indicates that CSSE is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.53, CSSE is not doing good in the industry: 72.37% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.53
Quick Ratio 0.53
CSSE Yearly Current Assets VS Current LiabilitesCSSE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for CSSE have decreased strongly by -151.68% in the last year.
The Revenue for CSSE has decreased by -36.32% in the past year. This is quite bad
The Revenue has been growing by 61.38% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-151.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.82%
Revenue 1Y (TTM)-36.32%
Revenue growth 3Y64.28%
Revenue growth 5Y61.38%
Sales Q2Q%-75%

3.2 Future

CSSE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.89% yearly.
CSSE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.04% yearly.
EPS Next Y42.18%
EPS Next 2Y62.8%
EPS Next 3Y39.86%
EPS Next 5Y23.89%
Revenue Next Year21.93%
Revenue Next 2Y18.06%
Revenue Next 3Y13.53%
Revenue Next 5Y10.04%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CSSE Yearly Revenue VS EstimatesCSSE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
CSSE Yearly EPS VS EstimatesCSSE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 -4 6 -6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CSSE. In the last year negative earnings were reported.
CSSE is valuated cheaply with a Price/Forward Earnings ratio of 0.03.
CSSE's Price/Forward Earnings ratio is rather cheap when compared to the industry. CSSE is cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.44, CSSE is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 0.03
CSSE Price Earnings VS Forward Price EarningsCSSE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150 200 250

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CSSE Per share dataCSSE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CSSE's earnings are expected to grow with 39.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y62.8%
EPS Next 3Y39.86%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CSSE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHICKEN SOUP FOR THE SOUL EN

NASDAQ:CSSE (7/2/2024, 8:13:23 PM)

After market: 0.054 -0.05 (-48.82%)

0.1055

-0.01 (-10.21%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-13 2024-05-13/amc
Earnings (Next)08-12 2024-08-12/amc
Inst Owners0.05%
Inst Owner Change0%
Ins Owners3.12%
Ins Owner Change0%
Market Cap3.42M
Analysts43.33
Price Target2.81 (2563.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.51
Dividend Growth(5Y)-0.36%
DP-1.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-72.95%
Min Revenue beat(2)-76.17%
Max Revenue beat(2)-69.74%
Revenue beat(4)0
Avg Revenue beat(4)-54.39%
Min Revenue beat(4)-76.17%
Max Revenue beat(4)-34.76%
Revenue beat(8)2
Avg Revenue beat(8)-23.46%
Revenue beat(12)2
Avg Revenue beat(12)-17.11%
Revenue beat(16)5
Avg Revenue beat(16)-11.51%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.03
P/S 0.02
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-20.06
EYN/A
EPS(NY)3.96
Fwd EY3751.28%
FCF(TTM)-0.45
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS6.54
BVpS-17.12
TBVpS-24.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -152.35%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-62.52%
ROA(5y)-47.4%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.79%
Cap/Sales 3.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.53
Quick Ratio 0.53
Altman-Z -4.31
F-Score2
WACC1.09%
ROIC/WACCN/A
Cap/Depr(3y)4.58%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.01%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-151.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.82%
EPS Next Y42.18%
EPS Next 2Y62.8%
EPS Next 3Y39.86%
EPS Next 5Y23.89%
Revenue 1Y (TTM)-36.32%
Revenue growth 3Y64.28%
Revenue growth 5Y61.38%
Sales Q2Q%-75%
Revenue Next Year21.93%
Revenue Next 2Y18.06%
Revenue Next 3Y13.53%
Revenue Next 5Y10.04%
EBIT growth 1Y-31.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year224.06%
EBIT Next 3Y56.56%
EBIT Next 5Y32.71%
FCF growth 1Y60.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y77.99%
OCF growth 3YN/A
OCF growth 5YN/A